Compounds > quinolinic acid

quinolinic acid and 2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine

quinolinic acid has been researched along with 2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Di Chiara, G; Fenu, S; Morelli, M; Pinna, A1
Caporali, MG; Pèzzola, A; Popoli, P; Reggio, R; Scotti de Carolis, A1
Gash, DM; Levivier, M; Przedborski, S1
Domenici, MR; Frank, C; Grieco, R; Martire, A; Pepponi, R; Pintor, A; Popoli, P; Potenza, RL; Tebano, MT1
Fuxe, K; Schwarcz, R; Wu, HQ1

Other Studies

5 other study(ies) available for quinolinic acid and 2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine

ArticleYear
Adenosine A2 receptors interact negatively with dopamine D1 and D2 receptors in unilaterally 6-hydroxydopamine-lesioned rats.
    European journal of pharmacology, 1994, Jan-04, Volume: 251, Issue:1

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenosine; Animals; Antihypertensive Agents; Autoradiography; Basal Ganglia; Benserazide; Binding Sites; Dopamine Agents; Ergolines; Levodopa; Male; Neural Pathways; Neurons; Oxidopamine; Phenethylamines; Quinolinic Acid; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Purinergic P1; Stereotyped Behavior

1994
CGS 21680 antagonizes motor hyperactivity in a rat model of Huntington's disease.
    European journal of pharmacology, 1994, May-12, Volume: 257, Issue:1-2

    Topics: Adenosine; Amphetamine; Animals; Disease Models, Animal; Huntington Disease; Male; Motor Activity; Phenethylamines; Quinolinic Acid; Rats; Rats, Wistar

1994
Time course of the neuroprotective effect of transplantation on quinolinic acid-induced lesions of the striatum.
    Neuroscience, 1995, Volume: 69, Issue:1

    Topics: Adenosine; Animals; Autoradiography; Benzazepines; Brain Diseases; Corpus Striatum; Electron Transport Complex IV; Fetal Tissue Transplantation; Isoquinolines; Male; Nerve Tissue; Phenethylamines; Quinolinic Acid; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, GABA-A; Receptors, Purinergic P1; Time Factors

1995
Adenosine A2A receptor blockade differentially influences excitotoxic mechanisms at pre- and postsynaptic sites in the rat striatum.
    Journal of neuroscience research, 2004, Jul-01, Volume: 77, Issue:1

    Topics: 4-Aminopyridine; Adenosine; Adenosine A2 Receptor Antagonists; Animals; Calcium; Corpus Striatum; Dose-Response Relationship, Drug; Glutamic Acid; In Vitro Techniques; L-Lactate Dehydrogenase; Male; Models, Biological; N-Methylaspartate; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Neurotoxins; Phenethylamines; Pyrimidines; Quinolinic Acid; Rats; Rats, Wistar; Receptor, Adenosine A2A; Receptors, N-Methyl-D-Aspartate; Synaptic Membranes; Synaptic Transmission; Triazines; Triazoles

2004
Neuronal A1 receptors mediate increase in extracellular kynurenic acid after local intrastriatal adenosine infusion.
    Journal of neurochemistry, 2004, Volume: 90, Issue:3

    Topics: Adenosine; Animals; Drug Administration Routes; Extracellular Fluid; Infusions, Parenteral; Kynurenic Acid; Male; Microdialysis; Neostriatum; Neurons; Phenethylamines; Quinolinic Acid; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Theophylline; Wakefulness

2004